Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35896237)

  • 1. Primary Central Nervous System Post-transplant Lymphoproliferative Disorder Misdiagnosed as Glioblastoma: A Case Report.
    Tanaka H; Matsuda R; Nakamura M; Nakagawa I; Nakase H
    Anticancer Res; 2022 Aug; 42(8):3975-3979. PubMed ID: 35896237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Primary central nervous system post-transplant lymphoproliferative disorders].
    Honda M; Koga M; Kanda T
    Brain Nerve; 2014 Aug; 66(8):947-54. PubMed ID: 25082316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Subacute cognitive impairment and urinary retention due to primary central nervous system post-transplant lymphoproliferative disorder: a case report].
    Yokoyama N; Kanbayashi T; Kobayashi S; Ishida T; Sonoo M
    Rinsho Shinkeigaku; 2021 Nov; 61(11):750-755. PubMed ID: 34657922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EBV-positive post-transplant lymphoproliferative disorder presenting as primary diffuse large B-cell lymphoma of the central nervous system.
    Xu H; Rewerska J; Aardsma N; Slavin K; Valyi-Nagy T; Ni H
    Folia Neuropathol; 2017; 55(3):221-226. PubMed ID: 28984115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].
    Chen DB; Wang Y; Song QJ; Shen DH
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):607-12. PubMed ID: 23157829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage.
    Crane GM; Powell H; Kostadinov R; Rocafort PT; Rifkin DE; Burger PC; Ambinder RF; Swinnen LJ; Borowitz MJ; Duffield AS
    Oncotarget; 2015 Oct; 6(32):33849-66. PubMed ID: 26460822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case series of primary central nervous system posttransplantation lymphoproliferative disorder: imaging and clinical characteristics.
    Lake W; Chang JE; Kennedy T; Morgan A; Salamat S; Başkaya MK
    Neurosurgery; 2013 Jun; 72(6):960-70; discussion 970. PubMed ID: 23685504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary CNS EBV-positive post-transplant lymphoproliferative disorder with polymorphic and classic Hodgkin lymphoma features: A case report and literature review.
    Mulligan M; Flavin R; Beausang A
    Clin Neuropathol; 2023; 42(4):161-167. PubMed ID: 37073959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry.
    Zimmermann H; Nitsche M; Pott C; Reinke P; Babel N; Hermann RM; Hauser IA; Hahn D; Ritgen M; Pietschmann C; Klapper W; Anagnostopoulos I; Trappe RU;
    Ann Hematol; 2021 Aug; 100(8):2043-2050. PubMed ID: 33973053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transplant primary central nervous system lymphoma after Epstein-Barr virus cerebellitis.
    Valencia-Sanchez C; Steenerson KK; Kelemen K; Orenstein R; Kusne S; Grill MF
    J Neurovirol; 2019 Apr; 25(2):280-283. PubMed ID: 30607891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility-weighted imaging and diffusion-weighted imaging findings in central nervous system monomorphic B cell post-transplant lymphoproliferative disorder before and after treatment and comparison with primary B cell central nervous system lymphoma.
    Ginat DT; Purakal A; Pytel P
    J Neurooncol; 2015 Nov; 125(2):297-305. PubMed ID: 26341369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report.
    Cavaliere R; Petroni G; Lopes MB; Schiff D;
    Cancer; 2010 Feb; 116(4):863-70. PubMed ID: 20052713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case report.
    Dutta R; Miao SY; Phan P; Fernandez-Pol S; Shiraz P; Ho D; Mannis GN; Zhang TY
    J Med Case Rep; 2021 Mar; 15(1):170. PubMed ID: 33773605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxoplasmic Encephalitis Followed by Primary EBV-Associated Post-Transplant Lymphoproliferative Disorder of the Central Nervous System in a Patient Undergoing Allogeneic Hematopoietic Stem Cell Transplant: A Case Report.
    Mayumi A; Yamashita T; Matsuda I; Hikosaka K; Fujino S; Norose K; Kato Y; Hirota S; Nakajima T; Ogawa H; Ikegame K
    Transplant Proc; 2020 Nov; 52(9):2858-2860. PubMed ID: 32873410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroimaging features of primary central nervous system post-transplantation lymphoproliferative disorder following hematopoietic stem cell transplant in patients with β-thalassemia: a case series and review of literature.
    Yang X; Deng X; Wu M; Chen SW; Jiang M; Long L; Chen BT
    Insights Imaging; 2024 Feb; 15(1):40. PubMed ID: 38353902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased MYC expression without MYC gene translocation in patients with the diffuse large B-cell-lymphoma subtype of iatrogenic immunodeficiency-associated lymphoproliferative disorders.
    Kabasawa N; Shiozawa E; Murai S; Homma M; Uesugi Y; Matsui T; Nakata A; Shimada S; Sasaki Y; Baba Y; Watanuki M; Arai N; Fujiwara S; Kawaguchi Y; Tsukamoto H; Uto Y; Yanagisawa K; Hattori N; Sakai H; Harada H; Nakamaki T; Takimoto M; Yamochi-Onizuka T
    J Clin Exp Hematop; 2021; 61(3):120-125. PubMed ID: 34511544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservative management of post-transplant central nervous system lymphoma.
    Valavoor SH; Ashraf Z; Narwal R; Ratnam S
    Int Urol Nephrol; 2013 Aug; 45(4):1219-22. PubMed ID: 22476860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation.
    Liu QF; Fan ZP; Luo XD; Sun J; Zhang Y; Ding YQ
    Transpl Infect Dis; 2010 Aug; 12(4):284-91. PubMed ID: 20345506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Epstein-Barr virus status and immunophenotypic studies in the evaluation of exfoliative cytology specimens from patients with post-transplant lymphoproliferative disorders.
    Gibson SE; Picarsic J; Swerdlow SH; Pantanowitz L
    Cancer Cytopathol; 2016 Jun; 124(6):425-35. PubMed ID: 26992116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary central nervous system posttransplantation lymphoproliferative disorder after heart and lung transplantation.
    Gifford G; Fay K; Jabbour A; Ma DD
    Intern Med J; 2015 May; 45(5):583-6. PubMed ID: 25955465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.